Aspire Biopharma Holdings (ASBP) Other Operating Expenses (2024 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Other Operating Expenses came in at $233482.0 in Q2 2026, up 167.8% year-over-year from $87186.0 in Q2 2025, and down 21.31% quarter-over-quarter from $296723.0 in Q1 2026.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Other Operating Expenses (2024 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Other Operating Expenses for 3 consecutive years, with $233482.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Operating Expenses rose 167.8% year-over-year to $233482.0 in Q2 2026; TTM through Jun 2026 was $831294.0, a 4374.44% increase from a year earlier, with the FY2025 full-year figure at $789829.0, up 526.38% from the prior year.
- Other Operating Expenses was $233482.0 for Q2 2026 at Aspire Biopharma Holdings, down from $296723.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $296723.0 in Q1 2026 and troughed at -$344381.0 in Q2 2025.
- A 3-year average of $73592.3 and a median of $95642.0 in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 2869.99% in 2025, down 298.48% in 2025.
- Over 3 years, Other Operating Expenses stood at $98094.0 in 2024, then decreased by 5.0% to $93190.0 in 2025, then surged by 150.54% to $233482.0 in 2026.
- The last three Other Operating Expenses figures came in at $233482.0 (Q2 2026), $296723.0 (Q1 2026), and $93190.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 233,482.00 |
| Mar 31, 2026 | 296,723.00 |
| Dec 31, 2025 | 93,190.00 |
| Sep 30, 2025 | 207,899.00 |
| Jun 30, 2025 | -344,381.00 |
| Mar 31, 2025 | 219,839.00 |
| Dec 31, 2024 | 98,094.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | -86,423.00 |
| Mar 31, 2024 | 10,500.00 |